Ultragenyx Pharmaceutical
RARE
RARE
172 hedge funds and large institutions have $2.51B invested in Ultragenyx Pharmaceutical in 2019 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 74 increasing their positions, 45 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
33% less capital invested
Capital invested by funds: $3.74B → $2.51B (-$1.23B)
60% less call options, than puts
Call options by funds: $3.13M | Put options by funds: $7.74M
Holders
172
Holding in Top 10
–
Calls
$3.13M
Puts
$7.74M
Top Buyers
| 1 | +$46.2M | |
| 2 | +$32.3M | |
| 3 | +$21.4M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$18.8M |
| 5 |
CII
Capital International Inc
Los Angeles,
California
|
+$17M |
Top Sellers
| 1 | -$138M | |
| 2 | -$22.1M | |
| 3 | -$19.5M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$18.7M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.88M |